Marco Cippitelli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Targeting RNA polymerase I to boost natural killer cell anticancer activity in multiple myeloma.
Journal: Cell death & disease
Published: May 26, 2025
NKG2D triggering hampers DNAM-1-mediated signaling in human NK cells.
Journal: Frontiers in immunology
Published: February 11, 2025
The senescence journey in cancer immunoediting.
Journal: Molecular cancer
Published: December 22, 2023
SUMOylation and related post-translational modifications in natural killer cell anti-cancer responses.
Journal: Frontiers in cell and developmental biology
Published: April 27, 2023
Cross-Dressing of Multiple Myeloma Cells Mediated by Extracellular Vesicles Conveying MIC and ULBP Ligands Promotes NK Cell Killing.
Journal: International journal of molecular sciences
Published: April 11, 2023
CD38 restrains the activity of extracellular cGAMP in a model of multiple myeloma.
Journal: iScience
Published: April 05, 2023
Doxorubicin-Mediated miR-433 Expression on Exosomes Promotes Bystander Senescence in Multiple Myeloma Cells in a DDR-Independent Manner.
Journal: International journal of molecular sciences
Published: February 28, 2023
NEDD8-activating enzyme inhibition potentiates the anti-myeloma activity of natural killer cells.
Journal: Cell death & disease
Published: December 30, 2022
Role of NF-κB Signaling in the Interplay between Multiple Myeloma and Mesenchymal Stromal Cells.
Journal: International journal of molecular sciences
Published: December 23, 2022
NKG2D engagement on human NK cells leads to DNAM-1 hypo-responsiveness through different converging mechanisms.
Journal: European journal of immunology
Published: September 30, 2022
GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells.
Journal: Frontiers in immunology
Published: May 12, 2022
Last Updated: 09/26/2026